Categories: NewsPharmaceutical

SmartSkin Launches Pharma Seal Assurance Solution to Deliver Real-Time Insights into Container Closure Integrity and Capping Performance

SmartSkin’s ISPE 4.0 debut redefines seal quality in pharma manufacturing.

FREDERICTON, NB, Dec. 1, 2025 /PRNewswire/ – SmartSkin Technologies, a leader in pharmaceutical manufacturing intelligence, today announced the availability of SmartSkin Seal Assurance, a breakthrough solution that gives pharmaceutical manufacturers real-time visibility into seal tightness leading to Container Closure Integrity across vial and cartridge capping. SmartSkin will debut the technology at the upcoming ISPE 4.0 in Barcelona, Spain, highlighting how analytics advance seal quality and reliability in pharmaceutical manufacturing.

SmartSkin Seal Assurance provides per-head, real-time feedback on sealing performance by measuring and visualizing forces during capping. Each event generates a digital signature, creating auditable proof that every capper head is configured and operating within specification. This record helps confirm setup quality and consistency. Compatible with single and multi-head systems, it complements Residual Seal Force (RSF) testing by confirming that sealing conditions measured in RSF are established from the start, closing the loop on Container Closure Integrity assurance.

“Despite the critical importance of seal quality for sterile products, translating the mechanical settings of capping equipment into the physical seal characteristics needed for container-closure performance has not been possible…until now,” said Dr. Mihaela Simianu, Scientific Advisor at SmartSkin Technologies. “SmartSkin’s Seal Assurance opens the possibilities to proactively build container closure integrity assurance into the aseptic process design, creating new possibilities to enhance equipment and process performance in measurable, controllable, and reliable ways

A recent implementation with one of the world’s largest pharma manufacturers demonstrated Seal Assurance’s ability to detect head-specific inconsistencies and identify optimal capping parameters, validating its role as a proactive control solution that enhances both quality and efficiency.

Seal Assurance supports applications from factory acceptance testing (FAT/SAT) and line qualification to routine setup verification and troubleshooting.

About SmartSkin Technologies

SmartSkin Technologies delivers manufacturing intelligence solutions that enable pharmaceutical producers to ensure quality, enhance patient safety, and eliminate costly production issues. By combining advanced Digital Container Twins with real-time analytics, SmartSkin helps manufacturers identify risks, prevent defects, and drive continuous improvement across complex fill-finish and packaging operations. Trusted by global leaders like Schott, Pfizer, and Sanofi, SmartSkin provides the precision and visibility needed to achieve zero-defect production and uphold the highest standards of pharmaceutical manufacturing excellence. Learn more at www.smartskintech.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/smartskin-launches-pharma-seal-assurance-solution-to-deliver-real-time-insights-into-container-closure-integrity-and-capping-performance-302628461.html

SOURCE SmartSkin Technologies

Staff

Recent Posts

Atropos Health Expands Oncology Precision Medicine Capabilities with Publication of New AI Algorithms for Rare Disease and Integration of ASCO Guidelines

Atropos Health is integrating the American Society of Clinical Oncology® (ASCO®) Guidelines into their platform…

5 hours ago

USF and Old Dominion to Play in the 2025 StaffDNA Cure Bowl

PLANO, Texas, Dec. 5, 2025 /PRNewswire/ -- Teams playing in the StaffDNA® Cure Bowl were…

5 hours ago

The Dot Corp Expands Services With New Promotional Products & Apparel Division

IRVINE, Calif., Dec. 5, 2025 /PRNewswire/ -- The Dot Corp has expanded its services with…

5 hours ago

Vaniam Group Launches Predictive Pathways: A New Capability for Anticipating Market-Shaping Signals

CHICAGO, Dec. 5, 2025 /PRNewswire/ -- Vaniam Group™, a category leader redefining medical communications, announced…

5 hours ago

Biorep Technologies Announces First Successful Independent Research Use of the PRISM System in Islet Isolation

Results confirm reproducibility and research readiness for islet isolation of Biorep's next generation laboratory platform.MIAMI,…

5 hours ago